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Abstract 
 
This study proposes a novel stochastic model for the study of hyposmotic hemolysis.  
This model is capable of reproducing both the kinetics in the transient phase and the lysis 
equilibrium in the stationary phase, as well as the variability of the experimental measurements. 
The stationary distribution of this model can be approximated to a normal distribution, with 
mean and variance related to the salt concentration used in the erythrocyte osmotic fragility 
assay. The proposed model can generalize the classical Boltzmann sigmoidal model often used 
in adjusting the stationary experimental data distribution. A typical osmotic fragility curve is 
constructed from the absorbance of free hemoglobin as a function of the decrease in NaCl (X) 
concentration and allows the determination of H50, an osmotic fragility variable that represents 
the saline concentration capable of promoting 50% lysis, and dX, an osmotic stability variable 
that represents ¼ of the variation in salt concentration required to promote 100% lysis. Based 
on the stationary distribution of the proposed model it is possible to stratify a population into 
different groups of individuals with similar levels of cell stability. These groups are very 
suitable to study the factors associated with cell stability, such as gender, age and lipids, among 
others. The method presented here was applied to a sample of 71 individuals and several results 
were obtained. In a group of 25 female subjects, with H50 values between 0.42 and 0.47 g/dL 
NaCl, for example, the use of a quadratic model to study the dependence of the stability index 
dX/H50 with blood LDL-cholesterol levels, showed that the erythrocyte osmotic stability 
increases with increasing LDL-C to a maximum value close to 90 mg/dL and then decreases. 
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Introduction 
 
 The erythrocyte is constantly exposed to several stressors, which may promote changes 
in its properties, such as deformability, which tends to decrease due to aggression promoted by 
reactive oxygen species (Cimen, 2008), for example. 
Red cell deformability may also be affected by changes in membrane cholesterol 
content (Cooper, Arner, Wiley, & Shattil, 1975; Hui, Stewart, Carpenter, & Stewart, 1980; Lee, 
Kim, Park, Song, & Lee, 2004), promoted by the interaction of this cell with plasma 
lipoproteins (Hung, Berisha, Ritchey, Santore, & Smith, 2012; Quarfordt & Hilderman, 1970), 
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in a process that will also affect other cellular properties, such as osmotic stability (Orbach, 
Zelig, Yedgar, & Barshtein, 2017). 
In turn, the osmotic stability of erythrocytes is related to several factors, which include 
the parameters and indices provided by a complete blood count, such as total hemoglobin (Hb) 
concentration, mean corpuscular hemoglobin concentration (MCHC), mean corpuscular 
volume (MCV), red-cell distribution width (RDW) and erythrocyte count (RBC) (M. V. de 
Freitas et al., 2014; Paraiso et al., 2017). 
The relationship of erythrocyte osmotic stability with RDW is noteworthy, since RDW 
elevation has been able to predict the aggravation of several diseases (Patel et al., 2010; 
Perlstein, Weuve, Pfeffer, & Beckman, 2009; Zurauskaite et al., 2018). A broader 
understanding of the factors that affect the erythrocyte osmotic stability should certainly shed 
more light on the pathological mechanisms associated with the predictive ability of RDW. 
In addition to osmotic stability, the kinetics of erythrocyte hyposmotic lysis, studied by 
Cunha and colleagues with the help of the classic Michaelis-Menten kinetic model, has also 
been shown to have important relationships with age, hematimetric parameters and lipidemia 
(Cunha et al., 2014). An empirical model composed of two exponential functions was also 
proposed by Gornicki to study hemolysis kinetics (Gornicki, 2008). However, none of these 
works presents a theoretical mathematical modeling for experimental variations of hemolysis 
rate. 
The aim of this paper was to present an unpublished stochastic model for the study of 
erythrocyte hyposmotic lysis. This model is capable of reproducing the lysis kinetics in the 
transient phase and the lysis equilibrium in the stationary phase, as well as the variability of 
experimental measurements. This enabled the development of a new method to group 
individuals with similar values of osmotic fragility. One among many possible applications of 
this method, the investigation of the influence of hematimetric and biochemical parameters on 
the erythrocyte stability was explored in this study, in order to evaluate the potential of the 
model. 
This is very relevant, since the osmotic stability of erythrocytes is an important clinical 
tool that has been applied not only in the diagnosis of erythrocytopathies, but also in the study 
of numerous diseases, such as diabetes mellitus (Rodrigues et al., 2018), preeclampsia (Aires 
Rodrigues de Freitas et al., 2018; M. A. R. de Freitas et al., 2019) and malaria (Mascarenhas 
Netto Rde et al., 2014), in processes such as aging (M. V. de Freitas et al., 2014; Penha-Silva 
et al., 2007) and clinical interventions such as physical exercise (Paraiso et al., 2017) and 
bariatric surgery (de Arvelos et al., 2013), among other situations. 
 
 
Material and Methods 
 
Collection of blood samples 
 
The blood samples used in this study were residual aliquots of blood from subjects who 
cannot be identified or contacted even if the results obtained could benefit them. Samples were 
collected by venipuncture directly into evacuated tubes containing 1g/dL K3EDTA as an 
anticoagulant (Vacutainer, Becton Dickinson, Juiz de Fora, MG, Brazil) after 8-12 hours 
fasting, in a clinical laboratory (LABORMED) of Uberlândia, MG, Brazil, and stored at 0 to 4 
°C for a maximum of 24 hours before testing. 
 
Reagents 
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All reagents used in the experiments had ACS grade of purity. The purity of NaCl 
(Labsynth, Diadema, SP, Brazil) used here was 99.5%, which was duly corrected in the 
preparation of its solutions. 
 
Equipment 
 
All weighings were done using a digital precision scale (AND, model 870, Japan) and 
volume measurements were made using automatic pipettes (Labsystems, Finnpipette Digital 
model, Helsinki, Finland). Incubations were performed in a thermostatic bath (Marconi, model 
MA 184, Piracicaba, SP, Brazil). Centrifugations were performed in a temperature controlled 
centrifuge (Hitachi Koki, model CF15RXII, Hitachinaka, Japan) and absorbance readings were 
taken on a UV-VIS spectrophotometer (Shimadzu, model UV1650TC, Japan).  
Blood counts were obtained on an automated system (Sysmex K4500, Sysmex 
Corporation, Mundelein, IL, USA). Total cholesterol (t-C), HDL-cholesterol (HDL-C), LDL-
cholesterol (LDL-C), VLDL-cholesterol (VLDL-C), triglycerides (TGC), and glucose (GLU) 
determinations were performed by an automated analyzer (Hitachi 917, Roche Diagnostics, 
Indianapolis, IN, USA). 
 
Experimental determination of erythrocyte osmotic stability 
 
A duplicate series of test tubes containing 1 mL of 0.1-1.0 g/dL NaCl solution was 
previously incubated at 37 °C in a thermostated water bath for 10 minutes. After adding 10 μL 
of whole blood to all tubes, they were gently shaken and incubated again at 37 °C for 30 
minutes. The samples were then centrifuged at 1600 x g for 10 minutes for supernatant 
separation and absorbance reading at 540 nm. 
The osmotic fragility curve was constructed for the dependence of the absorbance at 
540 nm (A) as a function of the NaCl (X) concentration, using a sigmoidal regression routine 
based on the Boltzmann equation, 
 
𝐴𝐴 = 𝐴𝐴𝑚𝑚𝑚𝑚𝑚𝑚−𝐴𝐴𝑚𝑚𝑚𝑚𝑛𝑛
1+ 𝑒𝑒(𝑋𝑋−𝐻𝐻50)/𝑑𝑑𝑋𝑋 + 𝐴𝐴𝑚𝑚𝑚𝑚𝑚𝑚                                               (1), 
 
in order to determine the values of the parameters Amax and Amin, which represent the 
absorbance values at 540 nm in the maximum and minimum sigmoid plateaus; H50, which 
represents the NaCl concentration capable of causing 50% hemolysis; and dX, which represents 
¼ of the variation in NaCl concentration responsible for the lysis of the whole erythrocyte 
population used in the assay (Bernardino Neto et al., 2013; Penha-Silva et al., 2007).  
 
Mathematical Modeling 
 
In assays performed to determine the erythrocyte osmotic stability, aliquots of blood 
are added at different NaCl concentrations and the suspensions obtained are incubated for 30 
minutes, a time interval which is sufficient for the occurrence of different lysis rates depending 
on the medium osmolarity. After this time, each mixture contains a specific amount of free 
hemoglobin in solution obtained from hemolysis under the osmolarity condition present 
therein. After centrifugation and separation of the supernatant, the measured absorbance 
expresses the free hemoglobin concentration, which does not strictly reflect the amount of cells 
lysed, since a red blood cell population shows heterogeneity in hemoglobin concentration and 
deformability. This is due to several factors such as the existence of differences in the lifetime 
of these cells, because as red cells age, younger cells, which are larger and more deformable, 
lose hemoglobin and become less deformable (Clark, 1988; Franco et al., 2013; Malka, 
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Delgado, Manalis, & Higgins, 2014). In addition, the heterogeneity of the erythrocyte 
population is greatly influenced by the conditions of supply of nutritional factors such as folate, 
cobalamin, pyridoxine, iron and proteins (Koury & Ponka, 2004). All of this must mean that 
the hemolysis rate, given by r = n/N, where n is the number of cells in lysis and N is the initial 
number of cells in the suspension, is difficult to measure at any given moment because it is 
under the influence of various factors that are difficult to control or even unknown, in addition 
to experimental variability. Therefore, r was considered a random variable in the discrete 
probabilistic model for the increase in hemolysis rate proposed here, ie, 
 
∆𝑟𝑟 =
⎩
⎪
⎨
⎪
⎧
            𝑃𝑃𝑟𝑟𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
−𝛾𝛾 𝑘𝑘2 ∗ 𝑛𝑛 ∗ ∆𝑃𝑃+𝛾𝛾 𝑘𝑘1 ∗ (𝑁𝑁 − 𝑛𝑛) ∗ ∆𝑃𝑃0 1 − �𝑘𝑘2 ∗ 𝑛𝑛 + 𝑘𝑘1 ∗ (𝑁𝑁 − 𝑛𝑛)� ∗ ∆𝑃𝑃                                      (2), 
 
where γ is a proportionality constant, n is the number of cells lysing at a given time, N is the 
number of intact cells at the initial time of mixing, k1 and k2 are constants that depend on salt 
concentration, and Δt is a small time interval. This model assumes that the hemolysis rate 
depends on the number of intact cells and the saline concentration in each solution used in the 
assay. 
In other words, the described model (Equation 2) assumes that the hemolysis rate may 
increase by +γ, with probability proportional to the number of intact cells, or decrease by –γ, 
with probability proportional to the number of cells that have been lysed. Thus, the greater the 
number of intact cells, the greater the chance hemolysis rate increase. On the other hand, the 
greater the number of lysed cells, the greater the chance of hemolysis rate decrease. Thus, the 
rate of hemolysis may increase or decrease at any moment, like a car always going in a certain 
direction, but changing speed, sometimes faster, sometimes slower. Both probabilities also 
depend on the saline conditions of the experiment, indicated by the constants k1 and k2. Thus, 
for each time increment, the hemolysis rate may increase or decrease according to the 
probabilities described in the model (Model 1). 
This discrete stochastic model (Equation 2) follows the recommendations of chapter 5 
of Allen (Allen, 2007) and can be approximated by a stochastic differential equation that has 
approximately the same probability distribution: 
 
𝑑𝑑𝑟𝑟 = 𝛾𝛾𝑁𝑁(𝑘𝑘1(1 − 𝑟𝑟) − 𝑘𝑘2𝑟𝑟)𝑑𝑑𝑃𝑃 + 𝛾𝛾√𝑁𝑁(�𝑘𝑘1(1 − 𝑟𝑟) + 𝑘𝑘2𝑟𝑟)𝑑𝑑𝑑𝑑              (3), 
 
where B is a replica of the Brownian movement. 
Considering γ = N-1 and ɛ = 1/√𝑁𝑁, Equation 3 becomes: 
 
𝑑𝑑𝑟𝑟 = (𝑘𝑘1(1 − 𝑟𝑟) − 𝑘𝑘2𝑟𝑟)𝑑𝑑𝑃𝑃 + 𝜀𝜀(�𝑘𝑘1(1 − 𝑟𝑟) + 𝑘𝑘2𝑟𝑟)𝑑𝑑𝑑𝑑                   (4). 
         
Further discussion of this approach is given in Appendix A. 
The first component of this equation is a measure the tendency, or drift, of rate over 
time, while the second component gives, of the variable r. For r ∈ [0 1], using the technique 
described by Grasman and van Herwaarden (Grasman & van Herwaarden, 2010), it is possible 
to prove that this model has a nearly normal stationary distribution, characterized by mean and 
variance shown in equations: 
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𝐸𝐸(𝑟𝑟) = 𝑘𝑘1
𝑘𝑘1+𝑘𝑘2
                                                           (5) 
 
and 
 
𝑑𝑑𝑑𝑑(𝑟𝑟) = 𝜀𝜀√𝑘𝑘1𝑘𝑘2
𝑘𝑘1+𝑘𝑘2
                                                        (6), 
respectively. 
This means that the hemolysis rate, given by r, will fluctuate over a long period of time 
around the average rate (Equation 5). 
With the model described by Equation 4, the average signal associated with the 
measurement of absorbance at 540 nm (Ā) can be studied in a simplified manner. For this we 
must consider that the red blood cell can generate two types of signals, the signal D, when it 
undergoes lysis, and signal L, when he does not suffer lysis (Figure 1).  
 
 
Fig. 1. Schematic representation of the mean signal obtained in the osmotic stability assay after 
centrifugation of the cell suspension. 
 
Thus, the average signal can be approximated by the sum of signal D of a lysed cell 
block multiplied by the number of lysed cells, with the signal L of a non-lysed cell block 
multiplied by the number of non-lysed cells, all divided by N. 
Thinking in terms of the detection limit of the apparatus, N should be interpreted as a 
minimum block of cells that, when lysed, generate a detectable response by the equipment. 
Thus, a test tube can be thought of as being grouped by several of these minimal erythrocyte 
blocks. Thus, N will depend on the sensitivity of the equipment used by the analysis. 
Although signal D and signal L are presumably constant, regardless of the individuals 
in a particular group, they may vary between different groups. Signal differences due to 
differences in the amount of hemoglobin in each erythrocyte, among other factors, can be 
modeled by variations in hemolysis rate, given by r, through Equation 6. 
All these assumptions were considered in an equation that allows the calculation of the 
average signal: 
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  ?̅?𝐴 = 𝐸𝐸(𝑆𝑆𝑚𝑚𝑆𝑆𝑚𝑚𝑆𝑆𝑆𝑆)
𝑁𝑁
= 𝑆𝑆𝑚𝑚𝑆𝑆𝑚𝑚𝑆𝑆𝑆𝑆 𝐷𝐷∗𝑁𝑁∗𝐸𝐸(𝑟𝑟)+𝑆𝑆𝑚𝑚𝑆𝑆𝑚𝑚𝑆𝑆𝑆𝑆 𝐿𝐿∗𝑁𝑁∗�1−𝐸𝐸(𝑟𝑟)�
𝑁𝑁
= 𝑆𝑆𝑃𝑃𝑆𝑆𝑛𝑛𝑃𝑃𝑃𝑃 𝐿𝐿 + (𝑆𝑆𝑃𝑃𝑆𝑆𝑛𝑛𝑃𝑃𝑃𝑃 𝐷𝐷 − 𝑆𝑆𝑃𝑃𝑆𝑆𝑛𝑛𝑃𝑃𝑃𝑃 𝐿𝐿) ∗ 𝑘𝑘1
𝑘𝑘1+𝑘𝑘2
       (7). 
 
The standard deviation of the average signal (SDĀ) can also be calculated using the 
following equation: 
 
       𝑆𝑆𝐷𝐷?̅?𝐴 = (𝑆𝑆𝑃𝑃𝑆𝑆𝑛𝑛𝑃𝑃𝑃𝑃 𝐷𝐷 − 𝑆𝑆𝑃𝑃𝑆𝑆𝑛𝑛𝑃𝑃𝑃𝑃 𝐿𝐿) ∗ 𝜀𝜀 ∗ √𝑘𝑘1𝑘𝑘2𝑘𝑘1+𝑘𝑘2                                  (8). 
 
Although the number of cells, indicated by N, are important to the model described by 
Equations 1, 2 and 3, the final expression used for calculating the expected average value of 
absorbance (Equation 7) does not depend explicitly on N, although signal D and signal L 
depend on the amount of hemoglobin, which is related to the number of cells or initial cell 
blocks used in the osmotic fragility assay and also to the spectrophotometer's detection 
capability.  
                                             
Choice of k1 and k2 
 
The choice of constants k1 and k2, which depend only on the salt concentration of each 
assay, can be made by different criteria, as was done in the following models: 
 
Model I: k1=1 and 𝑘𝑘2 = 𝑒𝑒𝑒𝑒𝑑𝑑 (𝑋𝑋−𝐻𝐻50
𝑑𝑑𝑋𝑋
), 
 
where X is the salt concentration, H50 is the salt concentration that causes a hemolysis rate (r) 
of 50% and dX is a model adjustment constant; 
 
Model II: k1= a and k2= 𝑒𝑒𝑒𝑒𝑑𝑑 (𝑋𝑋−𝐻𝐻50
𝑑𝑑𝑋𝑋
)+b, 
 
where the positive constants a and b satisfy the ratio a - b = 1, so that the expected value (E) 
of hemolysis rate (r) given by Equation 5 is 50% when X = H50; and 
  
Model III: k1=a and k2 = 100𝐻𝐻5
1+�
𝐻𝐻5
𝑋𝑋
�
𝑛𝑛 + 𝑃𝑃, 
 
where a, b and n are positive constants, H5 is the salt concentration responsible for r = 5%, and 
a e b satisfy the equation 0.95a - 0.05b = 2.5 H5 so that the expected value (E) of hemolysis 
rate (r), given by Equation 5, be 5% when X = H5. 
Model I was built based on the classical model of Boltzmann  (Dubois, Ouanounou, & 
Rouzaire-Dubois, 2009). Indeed, considering Amax = Signal D and Amin = Signal L, and 
substituting the values of k1 and k2 of this model in Equation 5, this equation is exactly equal 
to the Boltzmann equation: 
 
?̅?𝐴 = 𝑆𝑆𝑃𝑃𝑆𝑆𝑛𝑛𝑃𝑃𝑃𝑃 𝐿𝐿 + 𝑆𝑆𝑚𝑚𝑆𝑆𝑚𝑚𝑆𝑆𝑆𝑆 𝐷𝐷 − 𝑆𝑆𝑚𝑚𝑆𝑆𝑚𝑚𝑆𝑆𝑆𝑆 𝐿𝐿
𝑒𝑒(𝑋𝑋−𝐻𝐻50)/𝑑𝑑𝑋𝑋                                               (9). 
 
 Model 2 is an adaptation of Model 1 and Model 3 is an adaptation of the Hill model 
(Yasuhara & Kuroda, 2015).  
 
Confidence Intervals 
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Since equilibrium distribution of the hemolysis rate (r) given by Equation 4 
approximates a normal distribution, with mean given by Equation 5 and standard deviation 
given by Equation 6, it is possible to construct a confidence interval (CI) for r, with c% 
confidence, where typically c = 95, based on the following equation: 
 
𝐶𝐶𝐶𝐶(𝑐𝑐%) ≈ 𝑘𝑘1
𝑘𝑘1+𝑘𝑘2
± 𝜀𝜀𝑧𝑧𝑐𝑐√𝑘𝑘1𝑘𝑘2
𝑘𝑘1+𝑘𝑘2
                                                       (10). 
 
Equation 10 can also provide different estimates of H50, when confidence interval takes 
50%  the hemolysis rate, as illustrated in Figure 2. 
 
  
Fig. 2. Schematic representation of the confidence intervals given by Equations 11 and 12. 
 
 
The salt concentration whose CI(c%) of hemolysis rate (r) equals ½ represents an 
estimate of the true H50 of the studied population. This H50 is identified in Figure 2 as H50*. 
 
Groups Analysis 
 
Considering only H50 as a measure of cellular fragility, Equation 8, which allows the 
calculation of the hemolysis rate confidence interval, can be used to group individuals based 
on the proximity of H50 values.  
After determining the CI for a given individual's H50 value, the H50Ext values shown 
in Figure 2 can be estimated by the equations: 
 
 𝐻𝐻50𝐸𝐸𝐸𝐸𝐸𝐸  𝑚𝑚𝑃𝑃𝑒𝑒 = 𝐻𝐻50∗ + 2𝑧𝑧𝑐𝑐𝑑𝑑𝑑𝑑𝜀𝜀                                           (11) 
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and 
 
                                                  𝐻𝐻50𝐸𝐸𝐸𝐸𝐸𝐸  𝑚𝑚𝑃𝑃𝑛𝑛 = 𝐻𝐻50∗ − 2𝑧𝑧𝑐𝑐𝑑𝑑𝑑𝑑𝜀𝜀                                        (12), 
 
which are valid for Models I, II and III, since data dispersion of absorbance in average NaCl 
concentration region,  is similar in these three situations. 
Thus, all H50 values within the range limited by Equations 11 and 12 can be considered 
similar. 
The H50* and dX values present in Equations 11 and 12 are those obtained in the 
subject's cell fragility assay. 
The only parameter with unknown value in those equations is ɛ, derived from the 
stochastic model proposed in Equation 4. This parameter is related to the variability of cell 
fragility measurements, due to gender and age differences, among other factors. But we can 
point out three alternatives for estimating the value of ɛ. 
The first alternative involves the kinetics of hyposmotic erythrocyte lysis (Cunha et al., 
2014) at various time periods within the 30 minutes used in the cell fragility assay of the present 
study. 
Assuming that a particular set of individuals forms a group with common characteristics 
(such as gender, age, and pathological condition), a second alternative involves only the cell 
fragility assays to estimate the values of ɛ and the parameters of Model I, II or III. This can be 
done by the best fit of the expected values and standard deviation of each model with the mean 
values and standard deviation of the experimental data. 
A third alternative is to study, from the variation of ɛ, the possible groups existing in a 
set of individuals with cell fragility determined by Equation 4. In the hypothesis of a group of 
individuals presenting a chosen value of ɛ, it is possible to identify the individuals that are part 
of this group from the similarity of the values of their cell fragility parameters. 
Once a group of individuals has been characterized, it is possible to study, for example, 
the relationships between cell stability parameters, such as dX and H50, and even cell stability 
indices, such as dX/H50, with blood hematimetric and biochemical parameters, among others. 
 
Lysis Time 
 
In a study by Górnicki (Gornicki, 2008), the dependence of transmittance, T, as a function 
of time, t, is used to describe the average behavior of erythrocyte lysis kinetics, according to 
the empirical model given by the equation: 
 
𝑇𝑇(𝑃𝑃) = 𝐴𝐴 − 𝑑𝑑𝑒𝑒𝑒𝑒𝑑𝑑 �−𝐸𝐸
𝐸𝐸𝐵𝐵
� − 𝐶𝐶𝑒𝑒𝑒𝑒𝑑𝑑(−𝐸𝐸
𝐸𝐸𝐶𝐶
)                                            (13), 
 
where A represents lysis of the total cell population, B is lysis of the most rapidly lysed cell 
fraction, and C is lysis of the most slowly lysed cell fraction, such that A = B + C; and tB and 
tC represent the fast and slow lysis times, respectively. 
In terms of comparison, when erythrocyte geometry does not change, the author 
suggests that tB and tC may be related to fluidity and other hemolytic properties of the cell 
membrane, such as permeability to monovalent cations, such that the cell membrane is both 
less fluid, ie, more rigid, the longer it takes to reach steady state. 
The average behavior of the hemolysis rate (r) given by Equation 4 over time (t), ie r(t) 
, can be given by the equation: 
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𝐸𝐸�𝑟𝑟(𝑃𝑃)� = 𝑘𝑘1
𝐾𝐾1+𝑘𝑘2
(1 − exp(−(𝑘𝑘1 + 𝑘𝑘2)𝑃𝑃))                                     (14). 
 
 The Taylor series expansion of the exponential terms of Equation 13 for small time 
intervals allows Equation 15 to approximate the following equation:  
 
𝑇𝑇(𝑃𝑃) ≈ 𝐴𝐴�1 − 𝑒𝑒𝑒𝑒𝑑𝑑 �−�𝐵𝐵𝑡𝑡𝐶𝐶+𝐶𝐶𝑡𝑡𝐵𝐵𝐴𝐴 �𝐸𝐸
𝐸𝐸𝐵𝐵𝐸𝐸𝐶𝐶
��                                       (15). 
 
Since the transmittance measurements of the Górnicki experimental assays were made 
without centrifugation and, under this situation, T(t) is  proportional to r(t), it is then possible 
to compare Equation 14 with Equation 15. Thus, it is clear that the constant A in (Equation 13) 
is the same as that given by the average value of the steady state (Equation 14). Furthermore, 
an analysis of Equation 15, the term tBtC suggests dividing the constants k1 and k2 of the 
Equation 2 model by a new constant, called Lt,  related to the lysis time. This operation allows 
a better control of the dynamic stage of the lysis given by Equation 4 and, consequently, by the 
other models derived from it, without changing the average value and standard deviation of r(t) 
at the steady state, Equations (5) and (6). These new k1 and k2 constants, now called k1N and 
k2N, are related by approximation of Equations 13 and 14, according to the following equation: 
𝑘𝑘1𝑁𝑁 + 𝑘𝑘2𝑁𝑁 = 𝑘𝑘1+𝑘𝑘2
𝐿𝐿𝐸𝐸
= 𝐵𝐵
𝐴𝐴
�
1
𝐸𝐸𝐵𝐵
� + 𝐶𝐶
𝐴𝐴
�
1
𝐸𝐸𝐶𝐶
�                                      (16). 
    
The Lt parameter, which may be called overall lysis time to differentiate from tB and tC, 
influences the dynamic behavior of lysis and may be related to some characteristic of an 
individual and/or a subgroup of individuals that are part of a larger group with the same steady 
state hemolysis rate. This new constant can be measured in dynamic experiments. This topic 
has been added to show that the model given by Equation 1 and subsequent equations can 
reasonably represent the dynamic mean behavior of cell lysis by incorporating a new constant 
related to lysis time. However, the discussion of the results of this study involving steady state 
will be considering the use of k1 and k2 instead of k1N and k2N. 
 
Results and Discussion 
 
Sample Characteristics 
 
The study population consisted of 45 female and 26 male subjects. The baseline 
characteristics of the total and female study population can be seen in Table 1 and Table 2, 
respectively. 
  
Kinetic Behavior 
 
Figure 3 shows some numerical simulations of the stochastic model of Equation 4, at 
different saline concentrations, using Model II values of k1 e k2. 
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Fig. 3. Numerical simulation of the stochastic model given by Equation 3 for different salt 
concentrations using H50 = 0.45, dS = 0.02, a = 1.2, b = 0.2 and ɛ = 0.02 in all situations and 
Lt values of 1 (green line) and 10 (blue line). 
These simulations satisfactorily represent the temporal variation of the experimental 
hemolysis rate shown in Figure 1 of the study by Cunha and colleagues (Cunha et al., 2014), 
showing that the model considered in Equations 1-3 is able to adequately represent the kinetic 
behavior of the hemolysis rate. Furthermore, Figure 4 also shows the kinetic behavior described 
for hemolysis reported by Gornicki (Gornicki, 2008), showing that it is possible to control the 
speed with which the model reaches steady state using different values for the overall time of 
hemolysis (Lt).  
Groups Analysis 
Initially, the hypothesis that the group of 71 individuals analyzed constitutes a 
homogeneous population regarding cellular fragility was considered, only to show that the 
model can follow the variability of the measurements, even in a heterogeneous group regarding 
gender, age and other factors. The parameters of Models I, II and III were then identified as 
described in the Material and Methods section. 
Figure 4 shows the experimentally obtained values for the mean (Figure 4A) and 
standard deviation (Figure 4B) of those 71 subjects, compared to the mean and standard 
deviation values of the absorbance signals calculated using Model II, shown as solid blue lines 
in both figures. 
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A) 
 
B) 
 
 
 
Fig. 4. Mean (A) and standard deviation (B) values of the absorbance signals that were 
experimentally measured in the cell fragility assays (red balls) compared to the mean and 
standard deviation values determined based on Model II (solid blue line). 
 
 
 
 
The experimental data adjustments to Models I, II and III are shown in Figure 5. 
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Fig. 5. Fitting of the proposed models: Model I: H50 = 0.45, dS = 0.02, ɛ = 0.5, Signal L = 0.02 
and Signal D = 1.15 (A); Model II: H50 = 0.45, dS = 0.02, a = 1.2, b = 0.2, ɛ = 0.42, Signal L 
= 0.02 and Signal D = 1.35 (B); and Model III: H5 = 0.55, a = 1.46, b = 0.24, n = 20, ɛ = 0.4, 
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Signal L = 0.04 and Signal D = 1.4 (C). The solid red line represents the mean value and the 
blue lines delimit the confidence interval (95%) for the signal. 
 
All three models can represent the variability and mean value of the data in the H50 
region. However, Model I cannot represent data variability in the low and high NaCl 
concentration regions. Model II can represent the variability of the data in the region of low 
NaCl concentration, but also does not have good representation in the region of high 
concentration of NaCl. Finally, Model III can represent data variability and mean value in the 
three regions, that is, in the low, medium and high salt concentration regions. Barros and 
colleagues called these three regions of salt concentration phases in a study on the influence of 
different concentrations of essential oils on cell fragility in each of these phases (Barros et al., 
2016). Certainly the characterization of individuals regarding these phases may contribute to 
the understanding of the influence of different factors on their hematimetric characteristics. In 
addition, the use of Confidence Intervals generated by Models I, II and/or III may help in 
planning the evaluation of osmotic fragility of a new individual from the phase that best 
describes his/her osmotic fragility curve. But above all, these results suggest the existence of 
heterogeneity in osmotic fragility of erythrocytes.      
Considering now the hypothesis of heterogeneity in the osmotic fragility of the sample 
of 71 individuals studied here, given by the presence of subgroups with different levels of 
cellular fragility, the grouping technique proposed in the Material and Methods section was 
applied by the variation of the values of ɛ between 0.05 and 0.5. Some results of this analysis 
were shown in Figure 6.  
 
 
Fig. 6. Subjects whose H50 values are similar to those of individual # 12 (group 1) and 
individual # 26 (group 2) compared to subjects whose values of H50 are not similar to those 
two individuals (group 0). 
 
 
14 
 
 
 
This figure highlights individuals 12 and 26, who were chosen because they represent 
groups with higher and lower erythrocyte osmotic fragility, respectively. Thus, there would be 
a group of individuals similar to individual 12, with a value of ɛ = 0.1, and a group of 
individuals similar to individual 26, with ɛ = 0.25. 
The osmotic fragility curves of the groups of individuals with higher and lower cell 
fragility has been presented in Figure 7, along with the average line and the lines of the 95% 
confidence interval which was determined based on Model I. The separation of the two groups 
in the intermediate salt concentration region is quite evident. 
  
 
 
Fig. 7. Application of Model I (mean and 95% confidence interval) to the subgroups of major 
(blue circles) and minor (red circles) osmotic cell fragility of Figure 7.  
 
 
 
Finally, to highlight the potential of the technique of grouping individuals by similarity 
in cell stability from variation in the value of the parameter ɛ, some relationships found by 
linear regression analysis are used. Values of ɛ between 0.05 and 0.5 were chosen for this 
purpose. 
The first significant relation found is given by the following equation: 
 
𝑑𝑑𝑋𝑋
𝐻𝐻50
=  𝑃𝑃0  + 𝑃𝑃1 𝐿𝐿𝐷𝐷𝐿𝐿 +  𝑃𝑃2𝑀𝑀𝐶𝐶𝑀𝑀 ∗ 𝑅𝑅𝐷𝐷𝑅𝑅                                  (17), 
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where LDL, MCV and RDW represent, respectively, the blood levels of LDL-cholesterol and 
the values of mean corpuscular volume and red-cell distribution width. 
A group of 20 individuals with H50 values between 0.4005 and 0.4424 was found for ɛ 
= 0.15, but the largest group found occurred with ɛ = 0.45 and H50 values between 0.2959 and 
0.4443. This group comprised 26 individuals of the sample and the linear regression analysis 
described by Equation 18 for this group, given by the following equation: 
 
𝑑𝑑𝑋𝑋
𝐻𝐻50
=  0.136021 +  0.000202624 𝐿𝐿𝐷𝐷𝐿𝐿 −  0.00009.62565 𝑀𝑀𝐶𝐶𝑀𝑀 ∗ 𝑅𝑅𝐷𝐷𝑅𝑅        (18), 
 
showed significance (p < 0.05) for all model constants. Several smaller subgroups were found 
in this range of H50 and the regression analysis by Equation 17 always preserved the signals 
found for the values of a1 and a2 of Equation 18. But adjustment by Equation 17 was not 
statistically significant for both independent variables in any of the groups of individuals with 
H50 values above 0.4443.   
A clinical reading the results expressed by Equation 18 shows that for the 26 individuals 
with H50 in the range between 0.2959 and 0.4443, the osmotic stability of erythrocytes 
increases with an increase in LDL cholesterol and decrease in the standard deviation of MCV, 
since the product of MCV and RDW results in the standard deviation value of MCV. Moreover, 
since it is unlikely that there is an indefinite enhance in the osmotic stability of erythrocytes 
with increased LDL-C levels, this shall mean that Equation 18 provides evidence that such 
increase in the standard deviation of MCV is restricting the enhance in stability of erythrocytes 
with the increase in LDL-C levels. Since this enhance in MCV standard deviation means 
increased RDW, and LDL-C levels somehow reflect the membrane cholesterol content, it is 
possible that Equation 18 reflects the behavior of osmotic stability in response to increased 
cholesterol content in the erythrocyte membrane. Indeed, elevation in RDW values was 
associated with elevation in erythrocyte membrane cholesterol content (Tziakas et al., 2012). 
This is immensely relevant as it helps support the idea that changes in erythrocyte membrane 
cholesterol content is directly associated with the pathophysiology of atherosclerosis and its 
complications (da Silva Garrote-Filho, Bernardino-Neto, & Penha-Silva, 2017). 
Figure 8 highlights the relationship between H50 and dX for group (group 1) where 
Equation 17 was significant in relation to LDL and MCV*RDW compared to the other 
individuals in the sample (group 0). 
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Fig. 8. Group of individuals for whom the model given by Equation 17 is significant (group 1) 
compared to other individuals (group 0). 
 
 
 
 
The finding that LDL-C levels exert dualistic influence on erythrocyte stability deserves 
further analysis and therefore the sample of 71 subjects in this study was investigated for the 
existence of any group of individuals for which cell stability could be explained by a quadratic 
relationship with the LDL variable. The stratification of the sample by gender (45 females and 
26 males) was able to identify in the group of females several subgroups in which the quadratic 
relationship between cell stability and LDL is significant among individuals with H50 values 
between 0.42 and 0.47. The largest of these subgroups presents all female individuals (n = 25) 
found for values of ɛ = 0.25. In all these subgroups the quadratic term of LDL has negative sign 
and significant correlation with dX/H50. The quadratic relationship found (p <0.01) is given 
by the equation: 
 
𝑑𝑑𝑋𝑋
𝐻𝐻50
= −0.03143 + 0.001744 𝐿𝐿𝐷𝐷𝐿𝐿 − 0.000010 𝐿𝐿𝐷𝐷𝐿𝐿2                   (19), 
 
and the normality analysis of its residues by the Anderson Darling test does not reject the 
normality hypothesis (p = 0.52). Figure 9 shows this quadratic relationship between dX/H50 
erythrocyte stability index and LDL-C levels. 
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Fig. 9. Adjustment of the dependence of the osmotic stability index, dX/H50, with blood levels 
of LDL-cholesterol (Equation 17) for the female group identified by the model given by 
Equation 3. 
 
 
Figure 10 highlights the relationship of H50 values of these individuals as a function of 
their respective dX values compared to the other female subjects. This figure shows that 
Equation 19 is significant only for the female group with H50 values in a central range (0.42-
0.47) of the variability spectrum of this variable in the female population of the sample 
considered in this study. 
 
 
A) 
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B) 
 
 
 
Fig. 10. Female subjects for whom Equation 19 model is significant (group 1) compared to the 
other female subjects (group 0) (A) and all subjects of both sexes (B) for whom that model is 
not significant. 
 
 
The existence of a dualistic influence of LDL-C levels on erythrocyte stability is a very 
relevant issue and may help to understand the source of the antagonistic influence that blood 
cholesterol levels exert on blood cell count (Fessler, Rose, Zhang, Jaramillo, & Zeldin, 2013). 
 
 
Conclusions 
 
The stochastic model proposed here can reproduce the mean profile and data variability 
of the erythrocyte osmotic fragility assay of a group of individuals. This unprecedented 
technique allows to group individuals with similar values of cell fragility and from these groups 
to study the possible factors associated with erythrocyte stability, such as gender and 
erythrogram and lipidogram variables, for example. Moreover, the representation of lysis 
kinetics with a parameter called lysis time makes it possible to control the speed at which the 
rate of hemolysis reaches steady state. 
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Appendix A 
 
The model 1 can be written as follows: 
 
∆𝑟𝑟 =
⎩
⎪
⎨
⎪
⎧
            𝑃𝑃𝑟𝑟𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
−𝛾𝛾 𝑇𝑇−𝛾𝛾(𝑟𝑟) ∗ ∆𝑃𝑃+𝛾𝛾 𝑇𝑇+𝛾𝛾(𝑟𝑟) ∗ ∆𝑃𝑃0 1 − �𝑇𝑇+𝛾𝛾 + 𝑇𝑇−𝛾𝛾� ∗ ∆𝑃𝑃                                                         (A1) 
 
where T-γ (r) = k2n = k2Nr and  T+γ (r) = k1*(N – n) = k1 N (1 – r). 
Thus, the evolution of the probability distribution of Model A1 at time t + Δt, in terms 
of this distribution at time t, can be assessed by Equation A2, known as forward Kolmogorov 
equation: 
 
𝑃𝑃(𝑟𝑟, 𝑃𝑃 + ∆𝑃𝑃) = 𝑃𝑃(𝑟𝑟 − 𝛾𝛾, 𝑃𝑃)𝑇𝑇−𝛾𝛾(𝑟𝑟 − 𝛾𝛾)∆𝑃𝑃 + 𝑃𝑃(𝑟𝑟 + 𝛾𝛾, 𝑃𝑃)𝑇𝑇+𝛾𝛾(𝑟𝑟 + 𝛾𝛾)∆𝑃𝑃 + 𝑃𝑃(𝑟𝑟, 𝑃𝑃)(1 − 𝑇𝑇−𝛾𝛾(𝑟𝑟) − 𝑇𝑇𝛾𝛾(𝑟𝑟))𝛥𝛥𝑃𝑃    (A2) 
 
In the next step, applying the Taylor series in the first two terms on the right side of the 
equality A2, around r, produces: 
 
𝑃𝑃(𝑟𝑟 − 𝛾𝛾, 𝑃𝑃)𝑇𝑇−𝛾𝛾(𝑟𝑟 − 𝛾𝛾) = 𝑃𝑃(𝑟𝑟, 𝑃𝑃)𝑇𝑇−𝛾𝛾(𝑟𝑟) − 𝛾𝛾 𝜕𝜕(𝑃𝑃(𝑟𝑟,𝐸𝐸)𝑇𝑇−𝛾𝛾(𝑟𝑟))𝜕𝜕𝑟𝑟 + 12 𝛾𝛾2 𝜕𝜕2(𝑃𝑃(𝑟𝑟,𝐸𝐸)𝑇𝑇−𝛾𝛾(𝑟𝑟))𝜕𝜕𝑟𝑟2 + 𝑃𝑃(𝛾𝛾3)             (A3) 
 
and 
𝑃𝑃(𝑟𝑟 + 𝛾𝛾, 𝑃𝑃)𝑇𝑇+𝛾𝛾(𝑟𝑟 + 𝛾𝛾) = 𝑃𝑃(𝑟𝑟, 𝑃𝑃)𝑇𝑇+𝛾𝛾(𝑟𝑟) + 𝛾𝛾 𝜕𝜕(𝑃𝑃(𝑟𝑟,𝐸𝐸)𝑇𝑇+𝛾𝛾(𝑟𝑟))𝜕𝜕𝑟𝑟 + 12 𝛾𝛾2 𝜕𝜕2(𝑃𝑃(𝑟𝑟,𝐸𝐸)𝑇𝑇+𝛾𝛾(𝑟𝑟))𝜕𝜕𝑟𝑟2 + 𝑃𝑃(𝛾𝛾3)             (A4). 
 
Substituting Equations A3 and A4 into A2, assuming small values for γ and Δt, and 
simplifying, the expression for P(r,t) can be approximated by the solution of the partial 
differential equation known as the Fokker-Planck equation, resulting in: 
 
 𝜕𝜕𝜕𝜕(𝑟𝑟,𝐸𝐸)
𝜕𝜕𝐸𝐸
= −𝜕𝜕�𝛾𝛾�𝑇𝑇+𝛾𝛾(𝑟𝑟)−𝑇𝑇−𝛾𝛾(𝑟𝑟)�𝜕𝜕(𝑟𝑟,𝐸𝐸)�
𝜕𝜕𝑟𝑟
+ 1
2
𝜕𝜕2�𝛾𝛾2�𝑇𝑇+𝛾𝛾(𝑟𝑟)+𝑇𝑇−𝛾𝛾(𝑟𝑟)�𝜕𝜕(𝑟𝑟,𝐸𝐸)�
𝜕𝜕𝑟𝑟2                          (A5), 
 
or even in: 
 
  𝜕𝜕𝜕𝜕(𝑟𝑟,𝐸𝐸)
𝜕𝜕𝐸𝐸
= −𝜕𝜕(𝛾𝛾(𝑘𝑘1𝑁𝑁(1−𝑟𝑟)−𝑘𝑘2𝑁𝑁𝑟𝑟)𝜕𝜕(𝑟𝑟,𝐸𝐸))
𝜕𝜕𝑟𝑟
+ 1
2
𝜕𝜕2�𝛾𝛾2(𝑘𝑘1𝑁𝑁(1−𝑟𝑟)+𝑘𝑘2𝑁𝑁𝑟𝑟)𝜕𝜕(𝑟𝑟,𝐸𝐸)�
𝜕𝜕𝑟𝑟2                    (A6). 
 
Finally, the stochastic differential equation proposed by Model 2 has the same form as 
the Fokker-Planck equation (A6), as can be seen in Chapter 4 of Allen (Allen, 2007), for 
example. 
It is important to note that the same stochastic differential equation model (Equation 4) 
was deduced in a different context by Dangerfield and colleagues (Dangerfield, Kay, & 
Burrage, 2012).  These authors deduced a stochastic differential equation similar to Equation 
4 for study of ion channels. In addition, these authors also proposed a reflective edge condition 
at r = 0 and r = 1 so that the Equation 4 solution was always in the range [0 1]. Intuitively, the 
condition of reflective edges means that for r in the range [0 1] the dynamics for this variable 
follow Equation 4. When r assumes the values 0 or 1, it is rebated to the interval [0 1]. The 
study by Grasman and van Herwaarden (Grasman & van Herwaarden, 2010) presents a 
technique for obtaining an approximation of the probability distribution of Equation 4 under 
the condition of reflective edges used in this article. 
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